Chief Scientific Officer
Cabaletta Bio
Philadelphia, Pennsylvania, United States
Disclosure information not submitted.
TI3 - Emerging Therapeutics for Human Disease, Sponsored by AAI Clin. Immunol. Comm.
Friday, April 17, 2026
12:30 PM - 2:30 PM US ET
TI5 - Modeling the Human Immune Response, Sponsored by AAI Clin. Immunol. Comm.
Saturday, April 18, 2026
9:15 AM - 11:15 AM US ET